139
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Endothelial nitric oxide synthase (eNOS) (Glu298Asp) and urotensin II (UTS2 S89N) gene polymorphisms in preeclampsia: prediction and correlation with severity in Egyptian females

, &
Pages 292-303 | Received 27 Oct 2012, Accepted 29 Apr 2013, Published online: 01 Aug 2013

References

  • Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996;175:1365–70
  • Vatten LJ, Skjaerven R. Is preeclampsia more than one disease? BJOG 2004;111:298–302
  • Wilson JMG, Jungner G. Principles and practice of screening for disease. In: Public Health Paper Number 34. Geneva: WHO; 1968
  • Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001;357:53–6
  • Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200–4
  • Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S. Genetic effects on the liability of developing preeclampsia and gestational hypertension. Am J Med Genet 2000;91:256–60
  • Krotz S, Fajardo J, Ghandi S, et al. Hypertensive disease in twin pregnancies: a review. Twin Res 2002;5:8–14
  • Lachmeijer AM, Arngrimsson R, Bastiaans EJ. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamins status in women with a history of preeclampsia. Am J Obstet Gynecol 2001;184:394–402
  • Morgan L, Crawshaw S, Baker PN. Maternal and fetal angiotensinogen gene allele sharing in preeclampsia. Br J Obstet Gynaecol 1999;106:244–51
  • Kosmas IP, Tatsioni A, Ioannidis JP. Association of Leiden mutation in factor V gene with hypertension in pregnancy and preeclampsia: a meta-analysis. J Hypertens 2003;21:1221–8
  • Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361:865–72
  • Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 2001;38:1289–93
  • Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23 028 subjects. Circulation 2004;109:1359–65
  • Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet 2001;357:2002–6
  • Davenport AP, Maguire JJ. Urotensin II: fish neuropeptide catches orphan receptor. Trends Pharmacol Sci 2000;21:80–2
  • Ames RS, Sarau HM, Chambers JK, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999;401:282–6
  • Ong KL, Lam KS, Cheung BM. Urotensin II: its function in health and its role in disease. Cardiovasc Drugs Ther 2005;19:65–75
  • Vaudry H, Do Rego JC, Le Mevel JC, et al. Urotensin II, from fish to human. Ann N Y Acad Sci 2010;1200:53–66
  • El-Sherbiny W, Nasr A, Soliman A. Metalloprotease (ADAM12-S) as a predictor of preeclampsia: correlation with severity, maternal complications, fetal outcome, and doppler parameters. Hypertens Pregnancy 2012;31:442–50
  • El-Sherbiny WS, Soliman A, Nasr AS. Placental protein 13 as an early predictor in Egyptian patients with preeclampsia, correlation to risk, and association with outcome. J Investig Med 2012;60:818–22
  • El-Sherbiny W, Soliman A, El-Mazny A. Elevated serum-soluble Fas in preeclampsia: correlation with clinical, laboratory, and Doppler parameters. Hypertens Pregnancy 2011;30:221–30
  • Miyamoto Y, Saito Y, Kajiyama N, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998;32:3–8
  • Hibi K, Ishigami T, Tamura K, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998;32:521–6
  • Wang XL, Mahaney MC, Sim AS, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997;17:3147–53
  • Serrano NC, Paez C, Correa PA, Anaya JM. Endothelial nitric oxide synthase gene polymorphism is associated with systemic lupus erythematosus. J Rheumatol 2004;31:2163–8
  • Tamemoto H, Ishikawa SE, Kawakami M. Association of the Glu298Asp polymorphism of the eNOS Gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res Clin Pract 2008;80:275–9
  • Antoniades C, Tousoulis D, Vasiliadou C, et al. Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction. J Am Coll Cardiol 2005;46:1101–9
  • Gibson A. Complex effects of Gillichthys urotensin II on rat aortic strips. Br J Pharmacol 1987;91:205–12
  • Douglas SA, Ohlstein EH. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 2000;10:229–37
  • Chen LK, Huang CH, Yeh HM, et al. Polymorphisms in the endothelial nitric oxide synthase gene may be protective against preeclampsia in a Chinese population. Reprod Sci 2007;14:175–81
  • Shaik AP, Sultana A, Bammidi VK, et al. A meta-analysis of eNOS and ACE gene polymorphisms and risk of preeclampsia in women. J Obstet Gynaecol 2011;31:603–7
  • Yu CK, Casas JP, Savvidou MD, et al. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case--control study and a meta-analysis. BMC Pregnancy Childbirth 2006;6:7
  • Fatini C, Sticchi E, Gensini F, et al. Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow. J Hypertens 2006;24:1823–9
  • Kim YJ, Park BH, Park H, et al. No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations. Twin Res Hum Genet 2008;11:77–83
  • Singh A, Sharma D, Raghunandan C, Bhattacharjee J. Role of inflammatory cytokines and eNOS gene polymorphism in pathophysiology of pre-eclampsia. Am J Reprod Immunol 2010;63:244–51
  • Ozturk E, Balat O, Pehlivan S, et al. Endothelial nitric oxide synthase gene polymorphisms in preeclampsia with or without eclampsia in a Turkish population. J Obstet Gynaecol Res 2011;37:1778–83
  • Pappa KI, Roubelakis M, Vlachos G, et al. Variable effects of maternal and paternal--fetal contribution to the risk for preeclampsia combining GSTP1, eNOS, and LPL gene polymorphisms. J Matern Fetal Neonatal Med 2011;24:628–35
  • Sharma D, Singh A, Trivedi SS, Bhattacharjee J. Intergenotypic variation of nitric oxide and inflammatory markers in preeclampsia: a pilot study in a North Indian population. Hum Immunol 2011;72:436–9
  • Dikensoy E, Balat O, Ugur MG, et al. Association between urotensin II gene polymorphism and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2010;151:140–2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.